Nitric oxide modulates basal and endothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 7, 1997, Pages 1779-1789

  Rizvi, Mohammed A D ^b   Myers, Paul R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Angiotensin II; Collagen; Endothelin; Extracellular matrix; Nitric oxide; Restenosis; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ENDOTHELIN 1; NITRIC OXIDE;

ARTICLE; CORONARY ARTERY; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0031193675     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0480     Document Type: Article

References (56)

1. ANGELINI G, NEWBY A, 1989. The future of saphenous as a coronary artery bypass conduit. Eur Heart J 10: 273-280.
2. BJORNSSON J, EDWARDS W, 1985. Primary pulmonary hypertension: a histopathologic study of 80 cases. Mayo Clin Proc 60: 16-25.
3. BOLOTINA V, NAJIBI S, PALACINO J, PAGANO P, COHEN R, 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853.
4. BREDT D, SNYDER S, 1994. Nitric oxide: A physiologic messenger molecule. Ann Rev Biochem 63: 175-195.
5. BRUNE B, DIMMELER S, MOLINA Y, VEDIA L, LAPETINA E, 1994. Nitric oxide: a signal for ADP-ribosylation of proteins. Life Sci 54: 61-70.
6. BUCKLEY A, HILL K, DAVIDSON J, 1988. Collagen metabolism. Methods Enzymol 163: 674-694.
7. BURKE J, BALIAN G, ROSS R, BORNSTEIN P, 1977. Synthesis of types I and II procollagen and collagen by monkey aortic smooth muscle cells in vitro. Biochemistry 16: 3243-3249.
8. CHESEBRO J, LAM J, BADIMON L, FUSTER V, 1987. Restenosis after arterial angioplasty: a hemorheologic response to injury. Am J Cardiol 60: 10B-16B.
9. CHUA B, KREBS C, CHUA C, DIGLIO C, 1992. Endothelin stimulates protein synthesis in smooth muscle cells. Am J Physiol 262: E412-E416.
10. CLOWES A, REIDY M, CLOWES M, 1983. Mechanisms of stenosis after arterial injury. Lab Invest 49: 208-215.
11. CLOZEL M, FISCHLI W, GUILLI C, 1989. Specific binding of endothelin on human vascular smooth muscle cells in culture. J Clin Invest 83: 1758-1761.
12. CURRAN R, FERRARI F, KISPERT P, STADLER J, STUEHR D, SIMMONS R, BILLIAR T, 1991. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J 5: 2085-2092.
13. CURRIER J, FAXON D, 1995. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 25: 516-520.
14. DOUGLAS S, LOUDEN C, VICKERYCLARK L, STORER B, HART T, FEUERSTEIN G, ELLIOTT J, OHLSTEIN E, 1994. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty - Protective effects of the novel nonpeptide endothelin receptor antagonist SB209670. Circ Res 75: 190-197.
15. ENGVALL E, 1980. Enzyme immunoassay ELISA and EMIT. Methods Enzymol 70: 419-439.
16. GARG U, HASSID A, 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777.
17. GARG U, HASSID A, 1990. Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of balb/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochem Biophys Res Commun 171: 474-479.
18. GARG U, HASSID A, 1993. Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol 237: 243-249.
19. GOLIGORSKY M, TSUKAHARA H, MAGAZINE H, ANDERSEN T, MALIK A, BAHOU W, 1994. Termination of endothelin signaling: Role of nitric oxide. J Cell Physiol 158: 485-494.
20. GUARDA E, MYERS P, KATWA L, TYAGI S, WEBER K, 1993. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 27: 2130-2134.
21. GUO J, LEFER A, 1994. Stimulatory effect of a nitric oxide donor, CAS 754, on vascular endothelial cell proliferation (Abstract). Circulation 90: I-141.
22. HIRATA Y, YOSHIMI H, TAKAICHI S, YANAGISAWA M, MASAKI T, 1988. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett 239: 13-17.
23. IGNARRO L, 1989. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1-21.
24. KAHALEH M, 1991. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma: enhanced production and profibrotic action. Arthritis Rheum 34: 978-983.
25. KOLPAKOV V, GORDON D, KULIK T, 1995. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 76: 305-309.
26. KOLPAKOV V, REKHTER M, BAUMAN O, DI SCIULLO A, DI NARDO P, DROZDOV S, POGGI A, MIRONOV A, 1993. Endothelialized myointimal thickening in the rat aorta as a result of extensive freeze injury. Atherosclerosis 102: 187-193.
27. KOMURO I, KURIHARA H, SUGIYAMA T, TAKAKU F, YAZAKI Y, 1988. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238: 249.
28. MAORI J, BELL L, MARX M, MERWIN J, BASSON C, PRINZ C, 1991. Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: model of de-endothelialization and repair. J Cell Biochem 45: 123-130.
29. MARTIN E, MARSDEN P, BRENNER B, BALLERMANN B, 1989. Identification and characterization of endothelin binding sites in rat papillary and glomeruler membranes. Biochem Biophys Res Commun 162: 130-137.
30. MASAKI T, 1989. The discovery, the present state, and the future prospects of endothelin. J Cardiovasc Pharmacol 13 [Suppl. 5]: S1-S4.
31. MUNRO J, COTRAN R, 1988. The pathogenesis of atherosclerosis: atherogenesis and inflammation. J Lab Invest 58: 249-261.
32. MYERS P, GUERRA R, HARRISON D, 1989. Release of NO and EDRF from cultured bovine aortic endothelial cells. Am J Physiol 256: H1030-H1037.
33. MYERS P, MINOR R, GUERRA R, BATES J, HARRISON D, 1990. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163.
34. MYERS P, 1995. Vascular wound healing and restenosis. In: Weber K (ed.). Wound Healing Responses in Cardiovascular Diseases. Futura Publishing Co., 137-150.
35. NEWBY A, SOUTHGATE K, ASSENDER J, 1992. Inhibition of vascular smooth muscle cell proliferation by endothelium-dependent vasodilators. Herz 175: 291-299.
36. NUNOKAWA Y, TANAKA S, 1992. Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun 188: 409-415.
37. O'BRIEN E, ALPERS C, STEWARD D, 1993. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 73: 223-231.
38. OHLSTEIN E, DOUGLAS S, 1993. Endothelin modulates vascular smooth muscle structure and vasomotion: implications in cardiovascular pathology. Drug Dev Res 29: 108-128.
39. PALMER R, FERRIGE A, MONCADA S, 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
40. RIZVI M, KATWA L, SPADONE D, MYERS P, 1995. The effects of endothelin-1 on collagen type I and type III synthesis in cultured coronary artery vascular smooth muscle cells. J Mol Cell Cardiol 28: 243-252.
41. ROSS R, 1993. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature 362: 801-808.
42. SCOTT-BURDEN T, RESINK T, HAHN A, VANHOUTTE P, 1991. Induction of endothelin secretion by angiotensin-II -Effects on growth and synthetic activity of vascular smooth muscle cells. J Cardiovasc Pharmacol 17: S96-S100.
43. SCOTT-BURDEN T, VANHOUTTE P, 1993. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 87 [Suppl. V]: V51-V55.
44. STRAUSS B, CHISHOLM R, KEELEY F, GOTLIEB A, LOGAN R, ARMSTRONG P, 1994. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 75: 650-658.
45. SUGDEN P, FULLER S, MYNETT J, HATCHETT R, BOGOYEVITCH M, SUGDEN MC, 1993. Stimulation of adult rat ventricular myocyte protein synthesis and phosphoinositide hydrolysis by the endothelins. Biochem Biophys Acta 1175: 327-332.
46. SUZAKI S, SUZAKI A, YAMAMOTO Y, 1993. Specific hepatocyte endothelin receptors and the direct effect of endothelin on protein synthesis. Nippon Ika Daigaku Zasshi - J Nippon Med School 60: 223-230.
47. TAHARA A, KOHNO M, YANAGI S, ITAGANE H, TODA I, AKIOKA K, TERAGAKI M, YASUDA M, TAKEUCHI K, TAKEDA T, 1992. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism 225: 347-350.
48. TAKUWA Y, YANAGISAWA M, TAKUWA N, MASAKI T, 1989. Endothelin, its diverse biological activities and mechanisms of action. Progress In Growth Factor Research 1: 195-206.
49. TATRAI A, FOSTER S, LAKATOS P, SHANKAR G, STERN P, 1992. Endothelin-1 actions on resorption, collagen and non-collagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology 131: 603-607.
50. VANE J, ANGGARD E, BOTTIN R, 1990. Regulatory functions of the vascular endothelium. N Engl J Med 323: 27-36.
51. VON DER LEYEN H, GIBBONS G, MORISHITA R, LEWIS N, ZHANG L, NAKAJIMA M, KANEDA Y, COOKE J, DZAU V, 1995. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137-1141.
52. WALDMAN S, MURAD F, 1988. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 12 [Suppl. 5]: S115-S118.
53. WANG J, ZHAO G, SHEN W, OCHOA M, MOORE D, HUBBARD JW, HINTZE TH, 1993. Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failure. J Cardiovasc Pharmacol 22 [Suppl. 7]: S51-S58.
54. WEBER H, WEBB M, SERAFINO R, TAYLOR D, MORELAND S, NORMAN J, MOLLOY C, 1994. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells - Evidence for common signaling mechanisms. Mol Endocrinol 8: 148-158.
55. WEISSBERG P, WITCHELL C, DAVENPORT A, HESKETH T, METCALFE J, 1990. The Endothelin peptides ET-1, ET-2, ET-3 and Sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 85: 257-262.
56. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T, 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.